CVR number 32078486
Industry 32.5000 Manufacture of medical and dental instruments and supplies

DENTAL NORD ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  5.3% 2.8% 3.6% 4.6% 4.9%  
Credit score (0-100)  44 59 51 45 43  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1,189 1,566 1,372 1,179 1,384  
EBITDA  31.9 272 41.2 -291 -222  
EBIT  31.9 269 31.7 -300 -232  
Pre-tax profit (PTP)  28.5 262.5 22.7 -303.4 -231.6  
Net earnings  22.2 204.7 26.4 -235.0 -180.0  
Pre-tax profit without non-rec. items  28.5 262 22.7 -303 -232  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 44.0 34.6 25.1 15.7  
Shareholders equity total  988 1,193 1,162 870 631  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,358 1,585 1,416 1,171 1,048  
Net Debt  -859 -944 -831 -668 -439  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,189 1,566 1,372 1,179 1,384  
Gross profit growth  -32.8% 31.7% -12.4% -14.1% 17.4%  
Employees  0 3 0 0 3  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,358 1,585 1,416 1,171 1,048  
Balance sheet change%  1.0% 16.7% -10.7% -17.3% -10.5%  
Added value  31.9 272.4 41.2 -291.0 -222.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 41 -19 -19 -19  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 -1.0 -2.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2.7% 17.2% 2.3% -25.5% -16.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.4% 18.3% 2.1% -23.2% -20.9%  
ROI %  3.3% 24.7% 2.7% -29.6% -30.9%  
ROE %  2.3% 18.8% 2.2% -23.1% -24.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  72.7% 75.2% 82.1% 74.3% 60.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2,689.7% -346.5% -2,018.0% 229.4% 197.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  3.0 3.2 4.7 3.4 2.2  
Current Ratio  3.5 3.8 5.2 3.6 2.3  
Cash and cash equivalent  859.0 944.1 830.5 667.6 438.8  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  933.0 1,093.7 1,073.0 790.2 560.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 91 0 0 -74  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 91 0 0 -74  
EBIT / employee  0 90 0 0 -77  
Net earnings / employee  0 68 0 0 -60